C-X-C Motif Chemokine 12 Was Identified as a Potential Gene Target in the Treatment of Crohn’s Disease

Hongsai Hu, Rong He, Minji Liu, Hongbing Zhou, Lin Tan, Qiongjia Ai, Qian Wang, Luwei Zeng, Weiming Qu Department of Gastroenterology, Zhuzhou Hospital Affiliated to Xiangya Medical College, Central South University, Zhuzhou, 412000, People’s Republic of ChinaCorrespondence: Weiming Qu, Department o...

Full description

Saved in:
Bibliographic Details
Main Authors: Hu H, He R, Liu M, Zhou H, Tan L, Ai Q, Wang Q, Zeng L, Qu W
Format: Article
Language:English
Published: Dove Medical Press 2024-12-01
Series:International Journal of General Medicine
Subjects:
Online Access:https://www.dovepress.com/c-x-c-motif-chemokine-12-was-identified-as-a-potential-gene-target-in--peer-reviewed-fulltext-article-IJGM
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850119062304063488
author Hu H
He R
Liu M
Zhou H
Tan L
Ai Q
Wang Q
Zeng L
Qu W
author_facet Hu H
He R
Liu M
Zhou H
Tan L
Ai Q
Wang Q
Zeng L
Qu W
author_sort Hu H
collection DOAJ
description Hongsai Hu, Rong He, Minji Liu, Hongbing Zhou, Lin Tan, Qiongjia Ai, Qian Wang, Luwei Zeng, Weiming Qu Department of Gastroenterology, Zhuzhou Hospital Affiliated to Xiangya Medical College, Central South University, Zhuzhou, 412000, People’s Republic of ChinaCorrespondence: Weiming Qu, Department of Gastroenterology, Zhuzhou Hospital Affiliated to Xiangya Medical College, Central South University, Zhuzhou, 412000, People’s Republic of China, Email qwmq2q2@163.comObject: The present study aimed to identify hub genes associated with the treatment and control of active and inactive Crohn’s disease (CD).Methods: Differentially expressed genes (DEGs) were identified in normal, active CD, and inactive CD samples from GSE95095 dataset. Intersection genes screened by Venn diagram in DEGs. Subsequently, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were conducted on the intersection genes. The protein-protein interaction (PPI) network was used to screen of hub gene. The expression and mRNA levels of CXCL12 in CD and ROC curves in GSE95095 dataset. Signaling pathways of hub genes and their correlation with immune cells were analyzed by gene set enrichment analysis (GSEA), EPIC, and ESTIMATE, respectively. Finally, immunohistochemistry (IHC) and Reverse Transcription-Polymerase Chain Reaction (RT-PCR) were used to detect the expression of the hub gene in normal, inactive, and active CD tissues.Results: In GSE95095 dataset, CXCL12 was identified as the most hub gene by limma analysis, Venn diagram and A protein-protein interaction (PPI) network. CXCL12 expression was highest in active CD (p < 0.001) followed by inactive CD (p < 0.01). Subsequently, it was validated through IHC and RT-PCR in normal intestinal mucosal, active CD, and inactive CD. CXCL12 was overexpressed in active and inactive CD (IHC: p < 0.001 and RT-PCR: p < 0.001, respectively). CXCL12 expression in active CD was determined via analysis with receiver operating characteristic (ROC) curves. The specificity and sensitivity were 0.875 and 0.625, respectively, the accuracy was 72.92%, the area under the curve (AUC) was 0.780, and the 95% confidence interval (CI) was in the range of 0.648– 0.912. CXCL12 expression was closely correlated with various immune cells.Conclusion: CXCL12 is overexpressed in active CD and is closely correlated with various immune cells. We propose that CXCL12 as a potential target genes for the treatment and management of both active and inactive CD.Keywords: Crohn’s disease, C-X-C motif chemokine 12, gene target, immune cell
format Article
id doaj-art-4a73e7079b7d4ddebbe49e592189cd06
institution OA Journals
issn 1178-7074
language English
publishDate 2024-12-01
publisher Dove Medical Press
record_format Article
series International Journal of General Medicine
spelling doaj-art-4a73e7079b7d4ddebbe49e592189cd062025-08-20T02:35:43ZengDove Medical PressInternational Journal of General Medicine1178-70742024-12-01Volume 176219622898351C-X-C Motif Chemokine 12 Was Identified as a Potential Gene Target in the Treatment of Crohn&rsquo;s DiseaseHu HHe RLiu MZhou HTan LAi QWang QZeng LQu WHongsai Hu, Rong He, Minji Liu, Hongbing Zhou, Lin Tan, Qiongjia Ai, Qian Wang, Luwei Zeng, Weiming Qu Department of Gastroenterology, Zhuzhou Hospital Affiliated to Xiangya Medical College, Central South University, Zhuzhou, 412000, People’s Republic of ChinaCorrespondence: Weiming Qu, Department of Gastroenterology, Zhuzhou Hospital Affiliated to Xiangya Medical College, Central South University, Zhuzhou, 412000, People’s Republic of China, Email qwmq2q2@163.comObject: The present study aimed to identify hub genes associated with the treatment and control of active and inactive Crohn’s disease (CD).Methods: Differentially expressed genes (DEGs) were identified in normal, active CD, and inactive CD samples from GSE95095 dataset. Intersection genes screened by Venn diagram in DEGs. Subsequently, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were conducted on the intersection genes. The protein-protein interaction (PPI) network was used to screen of hub gene. The expression and mRNA levels of CXCL12 in CD and ROC curves in GSE95095 dataset. Signaling pathways of hub genes and their correlation with immune cells were analyzed by gene set enrichment analysis (GSEA), EPIC, and ESTIMATE, respectively. Finally, immunohistochemistry (IHC) and Reverse Transcription-Polymerase Chain Reaction (RT-PCR) were used to detect the expression of the hub gene in normal, inactive, and active CD tissues.Results: In GSE95095 dataset, CXCL12 was identified as the most hub gene by limma analysis, Venn diagram and A protein-protein interaction (PPI) network. CXCL12 expression was highest in active CD (p < 0.001) followed by inactive CD (p < 0.01). Subsequently, it was validated through IHC and RT-PCR in normal intestinal mucosal, active CD, and inactive CD. CXCL12 was overexpressed in active and inactive CD (IHC: p < 0.001 and RT-PCR: p < 0.001, respectively). CXCL12 expression in active CD was determined via analysis with receiver operating characteristic (ROC) curves. The specificity and sensitivity were 0.875 and 0.625, respectively, the accuracy was 72.92%, the area under the curve (AUC) was 0.780, and the 95% confidence interval (CI) was in the range of 0.648– 0.912. CXCL12 expression was closely correlated with various immune cells.Conclusion: CXCL12 is overexpressed in active CD and is closely correlated with various immune cells. We propose that CXCL12 as a potential target genes for the treatment and management of both active and inactive CD.Keywords: Crohn’s disease, C-X-C motif chemokine 12, gene target, immune cellhttps://www.dovepress.com/c-x-c-motif-chemokine-12-was-identified-as-a-potential-gene-target-in--peer-reviewed-fulltext-article-IJGMcrohn’s diseasec-x-c motif chemokine 12gene targetimmune cell
spellingShingle Hu H
He R
Liu M
Zhou H
Tan L
Ai Q
Wang Q
Zeng L
Qu W
C-X-C Motif Chemokine 12 Was Identified as a Potential Gene Target in the Treatment of Crohn&rsquo;s Disease
International Journal of General Medicine
crohn’s disease
c-x-c motif chemokine 12
gene target
immune cell
title C-X-C Motif Chemokine 12 Was Identified as a Potential Gene Target in the Treatment of Crohn&rsquo;s Disease
title_full C-X-C Motif Chemokine 12 Was Identified as a Potential Gene Target in the Treatment of Crohn&rsquo;s Disease
title_fullStr C-X-C Motif Chemokine 12 Was Identified as a Potential Gene Target in the Treatment of Crohn&rsquo;s Disease
title_full_unstemmed C-X-C Motif Chemokine 12 Was Identified as a Potential Gene Target in the Treatment of Crohn&rsquo;s Disease
title_short C-X-C Motif Chemokine 12 Was Identified as a Potential Gene Target in the Treatment of Crohn&rsquo;s Disease
title_sort c x c motif chemokine 12 was identified as a potential gene target in the treatment of crohn rsquo s disease
topic crohn’s disease
c-x-c motif chemokine 12
gene target
immune cell
url https://www.dovepress.com/c-x-c-motif-chemokine-12-was-identified-as-a-potential-gene-target-in--peer-reviewed-fulltext-article-IJGM
work_keys_str_mv AT huh cxcmotifchemokine12wasidentifiedasapotentialgenetargetinthetreatmentofcrohnrsquosdisease
AT her cxcmotifchemokine12wasidentifiedasapotentialgenetargetinthetreatmentofcrohnrsquosdisease
AT lium cxcmotifchemokine12wasidentifiedasapotentialgenetargetinthetreatmentofcrohnrsquosdisease
AT zhouh cxcmotifchemokine12wasidentifiedasapotentialgenetargetinthetreatmentofcrohnrsquosdisease
AT tanl cxcmotifchemokine12wasidentifiedasapotentialgenetargetinthetreatmentofcrohnrsquosdisease
AT aiq cxcmotifchemokine12wasidentifiedasapotentialgenetargetinthetreatmentofcrohnrsquosdisease
AT wangq cxcmotifchemokine12wasidentifiedasapotentialgenetargetinthetreatmentofcrohnrsquosdisease
AT zengl cxcmotifchemokine12wasidentifiedasapotentialgenetargetinthetreatmentofcrohnrsquosdisease
AT quw cxcmotifchemokine12wasidentifiedasapotentialgenetargetinthetreatmentofcrohnrsquosdisease